Viral Breakthrough during Lamivudine Therapy for Chronic Hepatitis B

Publisher： Karger

E-ISSN： 1423-0100|46|6|344-349

ISSN： 0300-5526

Source： Intervirology, Vol.46, Iss.6, 2003-12, pp. : 344-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Virological and Biochemical Relapse after Discontinuation of Lamivudine Monotherapy for Chronic Hepatitis B in Japan: Comparison with Breakthrough Hepatitis during Long-Term Treatment

By  

Intervirology, Vol. 48, Iss. 2-3, 2005-03 ,pp. : 174-182

Karger

Access to resources Recommend Favorite

Continued Lamivudine Therapy in Patients with Chronic Hepatitis B

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 377-387

Karger

Access to resources Recommend Favorite

Polymerase Domain B Mutation Is Associated with Hepatitis Relapse during Long-Term Lamivudine Therapy for Chronic Hepatitis B

By  

Intervirology, Vol. 48, Iss. 6, 2005-07 ,pp. : 381-388

Karger

Access to resources Recommend Favorite

Hepatitis B Genotypes in Chronic Hepatitis B and Lamivudine Therapy

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 373-376

Karger

Access to resources Recommend Favorite

The Feasibility of Discontinuing Lamivudine in Lamivudine-Resistant Chronic Hepatitis B Patients on Lamivudine and Adefovir Combination Therapy

By  

Intervirology, Vol. 57, Iss. 6, 2014-09 ,pp. : 337-343

Karger

Access to resources Recommend Favorite